Table 2.

Glycosylated hemoglobin (HbA1c) levels, poor glycemic control rates, insulin dosages, BMI, and frequency of blood glucose monitoring in the experimental (1A, 2A) and control (1B, 2B) groups.

	T0	T1	T2	T3	T4/T5
HbA1c level (%)
Group 1A	8.03 ± 1.41	7.35 ± 1.24△	7.37 ± 1.00△	7.61 ± 1.22	7.61 ± 1.15
Group 1B	8.01 ± 1.92	7.89 ± 2.05	8.21 ± 2.05	8.41 ± 2.04	8.72 ± 1.81△
P*	0.40	0.10	<0.01	<0.01	<0.01
Group 2A	8.39 ± 1.23	8.49 ± 1.40	8.36 ± 1.25	9.03 ± 1.59	9.24 ± 1.43
Group 2B	8.67 ± 1.44	9.04 ± 1.96	9.19 ± 1.79△	8.96 ± 1.94	9.28 ± 1.75△
P †	0.87	0.48	0.04	0.92	0.40
Poor glycemic control rate (%)
Group 1A	18	11.5	4.9	13.2	15.4
Group 1B	22.1	24	32.8	28.6	32.7
P*	0.52	0.04	<0.01	0.03	0.04
Group 2A	30.4	26.1	21.7	47.8	45
Group 2B	45.7	43.5	50	37.8	54.1
P †	0.23	0.16	0.02	0.43	0.51
Insulin dosage (U/kg/d)
Group 1A	0.59 ± 0.36	0.54 ± 0.29	0.58 ± 0.26	0.68 ± 0.17	0.76 ± 0.19△
Group 1B	0.39 ± 0.24	0.41 ± 0.23	0.47 ± 0.22△	0.57 ± 0.23△	0.70 ± 0.25△
P*	<0.01	<0.01	<0.01	<0.01	<0.01
Group 2A	0.58 ± 0.27	0.72 ± 0.27	0.79 ± 0.25△	0.82 ± 0.28△	0.84 ± 0.16△
Group 2B	0.66 ± 0.23	0.69 ± 0.23	0.71 ± 0.21△	0.74 ± 0.20△	0.83 ± 0.24△
P †	0.19	0.42	0.24	0.16	0.67
BMI (kg/m2)
Group 1A	16.74 ± 2.26	17.17 ± 2.00△	17.25 ± 2.01	17.61 ± 1.22△	17.61 ± 1.15
Group 1B	16.57 ± 1.92	16.57 ± 2.08	16.60 ± 2.07	16.96 ± 2.07△	17.21 ± 2.49△
P*	0.61	0.02	0.02	0.03	0.53
Group 2A	17.54 ± 1.97	18.13 ± 1.99△	18.70 ± 2.67△	18.75 ± 2.34△	19.50 ± 3.08△
Group 2B	17.12 ± 2.45	17.39 ± 2.54	17.73 ± 2.41	17.73 ± 2.57	17.62 ± 2.59△
P †	0.48	0.07	<0.01	0.03	0.05
Blood glucose monitoring ≥4 times/day (%)
Group 1A	76.30	71.80	63.40	43.20	40.00
Group 1B	62.00	54.00	51.00	38.50	47.90
P*	0.05	0.09	0.24	0.65	0.49
Group 2A	70.00	66.70	42.90	33.30	28.60
Group 2B	31.30	31.30	30.80	21.40	8.30
P †	0.13	0.06	0.52	0.47	0.18

∗Group 1A versus group 1B; ^†group 2A versus group 2B; ^△ P < 0.05 versus baseline.